Results 21 to 30 of about 19,821,917 (190)

Vitamin K antagonist use and renal function in pre-dialysis patients

Clinical Epidemiology, 2018
Pauline WM Voskamp,1 Friedo W Dekker,1 Maarten B Rookmaaker,2 Marianne C Verhaar,2 Willem Jan W Bos,3 Merel van Diepen,1 Gurbey Ocak2 1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands; 2Department of ...
Voskamp PWM, Dekker FW, Rookmaaker MB, Verhaar MC, Bos WJW, van Diepen M, Ocak G   +6 more
doaj   +1 more source

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis.

PLoS ONE, 2015
BackgroundUse of the non-vitamin K antagonist oral anticoagulants (NOACs) is endorsed by current guidelines for stroke prevention in patients with atrial fibrillation (AF).
Giuseppe Santarpia, Salvatore De Rosa, Alberto Polimeni, Salvatore Giampà, Mariella Micieli, Antonio Curcio, Ciro Indolfi   +6 more
doaj   +2 more sources

Safe administration of non-vitamin K antagonist oral anticoagulants

Nurse Prescribing, 2017
Atrial fibrillation (AF) is the most common type of cardiac arrhythmia. More than 1 million people in the UK have AF, and it is more prevalent in older people. It increases the risk of stroke fivefold ( Stroke Association, 2016a ). In 2009, non-vitamin K antagonist anticoagulants (NOACs) were integrated into clinical practice for the treatment of ...
Elmer J Catangui
openaire   +2 more sources

The safety of new oral anticoagulants for ischemic stroke and systemic embolism prevention in females with atrial fibrillation [PDF]

Romanian Journal of Neurology, 2021
The prevalence of atrial fibrillation is lower in females than in men, but the risk of stroke and systemic thromboembolism is comparable or even higher. Administration of anticoagulant therapy does not modify this difference. Two classes of non-vitamin K
Despina-Manuela Toader, Ileana Neaca, Alina Paraschiv, Rodica Musetescu   +3 more
doaj   +1 more source

Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis

Anatolian Journal of Cardiology, 2022
Background: The meta-analysis of randomized controlled trials has illustrated that the efficacy of low-dose non-vitamin K antagonist oral anticoagulants is inferior compared with standard-dose non-vitamin K antagonist oral anticoagulants, though they are
Zei Li, Yingming Zheng, Dandan Li, Xiaozhen Wang, Sheng Cheng, Xiao Luo, Aiping Wen   +6 more
doaj   +1 more source

Progress in the Application of Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation and Chronic Renal Insufficiency

Xiehe Yixue Zazhi, 2022
Oral anticoagulants can effectively reduce the risk of stroke in patients with atrial fibrillation. However, patients with atrial fibrillation and chronic renal insufficiency have an increased risk in both stroke and bleeding, making anticoagulant ...
LI Xin, LIU Lu, LIU Zhihong, ZHAO Zhihui, LUO Qin, ZHAO Qing   +5 more
doaj   +1 more source

Efficacy and safety of non-vitamin K antagonist oral anticoagulants for venous thromboembolism: a meta-analysis

JRSM Open, 2021
Objective Several trials had compared the efficacy and safety between non-vitamin K antagonist oral anticoagulants and warfarin for acute venous thromboembolism, but the results were incomplete.
Yan Zhuang, Lin-feng Dai, Ming-qi Chen
doaj   +1 more source

Safety and differences between direct oral anticoagulants and vitamin K antagonists in the risk of post-traumatic intrathoracic bleeding after rib fractures in elderly patients

Emergency Care Journal, 2021
Closed chest traumas are frequent consequences of falls in the elderly. The presence of concomitant oral anticoagulant therapy can increase the risk of post-traumatic bleeding even in cases of trauma with non-severe dynamics. There is limited information
Gianni Turcato, Arian Zaboli, Andrea Tenci, Giorgio Ricci, Massimo Zannoni, Christoph Scheurer, Anton Wieser, Antonio Maccagnani, Antonio Bonora, Norbert Pfeifer   +9 more
doaj   +1 more source

Effects of oral anticoagulants on bone health (systematic literature review)

Bolʹ, Sustavy, Pozvonočnik, 2023
Background. Osteoporosis is actually today's problem, as it affects the quality and length of life, and increases the risk of fragility fractures, which leads to significant medical, social, and economic problems.
H.V. Mostbauer, T.A. Karasevska, L.P. Antonenko, Iu.V. Rudenko, A.B. Bezrodnyi   +4 more
doaj   +1 more source

The Role of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation: Treatment Management Based on Patient and Drug Characteristics

, 2022
Data from Turkey revealed that atrial fibrillation patient percentage under adequate anticoagulation in Turkey is less than that in other countries due to multiple parameters such as treatment adherence problems, failure to follow guideline ...
Erdem Gürkaş, Serkan Çay, Gurkas, Erdem, Cihangir Kaymaz, Kadriye Kılıçkesmez, Göksel Çağırıcı, Kaymaz, Cihangir, Uğur Arslan, Selçuk Kanat, Arslan, Ugur, Cagirici, Goksel, Kilickesmez, Kadriye, Oktay Ergene, Gonen, Can, Kilickap, Mustafa, Can Gönen, Fahriye Vatansever, Aras, Dursun, Ozpelit, Ebru, Cay, Serkan, Kanat, Selcuk, Ebru Özpelit, Mustafa Kılıçkap, Ethem Murat Arsava, Arsava, Ethem Murat, Dursun Aras, Ergene, Oktay, Vatansever, Fahriye   +27 more
core   +1 more source